[
  {
    "ts": "2026-01-17T05:09:52+00:00",
    "headline": "Is Abbott Laboratories (ABT) Price Weakness Creating A Potential Opportunity Now?",
    "summary": "If you are wondering whether Abbott Laboratories' current share price around US$121.76 offers solid value, you are not alone. This article is here to break that question down in plain terms. The stock has seen a 3.3% decline over the last 7 days and a 3.9% decline over the last 30 days, while its 1 year return sits at 9.3%. This gives you a mix of recent weakness and longer term gains to think about. Recent attention on Abbott often centers on its broad healthcare product portfolio and how...",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-price-weakness-050952171.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "2218a7e2-c270-30ff-a6f0-6491658c7227",
      "content": {
        "id": "2218a7e2-c270-30ff-a6f0-6491658c7227",
        "contentType": "STORY",
        "title": "Is Abbott Laboratories (ABT) Price Weakness Creating A Potential Opportunity Now?",
        "description": "",
        "summary": "If you are wondering whether Abbott Laboratories' current share price around US$121.76 offers solid value, you are not alone. This article is here to break that question down in plain terms. The stock has seen a 3.3% decline over the last 7 days and a 3.9% decline over the last 30 days, while its 1 year return sits at 9.3%. This gives you a mix of recent weakness and longer term gains to think about. Recent attention on Abbott often centers on its broad healthcare product portfolio and how...",
        "pubDate": "2026-01-17T05:09:52Z",
        "displayTime": "2026-01-17T05:09:52Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7zJOBZ6wPnYKbKPRmWh.qQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/sc9EgsXKjWnUzlOQpxWhqQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/9233d293790357e156ec19f81dd7a7d9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-price-weakness-050952171.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-price-weakness-050952171.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]